BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 22998785)

  • 1. Duration of colonization by extended-spectrum β-lactamase-producing Enterobacteriaceae after hospital discharge.
    Birgand G; Armand-Lefevre L; Lolom I; Ruppe E; Andremont A; Lucet JC
    Am J Infect Control; 2013 May; 41(5):443-7. PubMed ID: 22998785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.
    Freeman JT; McBride SJ; Nisbet MS; Gamble GD; Williamson DA; Taylor SL; Holland DJ
    Int J Infect Dis; 2012 May; 16(5):e371-4. PubMed ID: 22401750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia.
    Reddy P; Malczynski M; Obias A; Reiner S; Jin N; Huang J; Noskin GA; Zembower T
    Clin Infect Dis; 2007 Oct; 45(7):846-52. PubMed ID: 17806048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany.
    Lübbert C; Straube L; Stein C; Makarewicz O; Schubert S; Mössner J; Pletz MW; Rodloff AC
    Int J Med Microbiol; 2015 Jan; 305(1):148-56. PubMed ID: 25547265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Gastrointestinal Colonization Rate with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Hospitalized Patients: Emergence of Carbapenemase-Producing K. pneumoniae in Ethiopia.
    Desta K; Woldeamanuel Y; Azazh A; Mohammod H; Desalegn D; Shimelis D; Gulilat D; Lamisso B; Makonnen E; Worku A; Mannerqvist K; Struwe J; Aspevall O; Aklillu E
    PLoS One; 2016; 11(8):e0161685. PubMed ID: 27574974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decolonization of intestinal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial.
    Huttner B; Haustein T; Uçkay I; Renzi G; Stewardson A; Schaerrer D; Agostinho A; Andremont A; Schrenzel J; Pittet D; Harbarth S
    J Antimicrob Chemother; 2013 Oct; 68(10):2375-82. PubMed ID: 23719234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proportion of rectal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in the inpatients of a pediatric tertiary care hospital in Japan.
    Minami K; Shoji Y; Kasai M; Ogiso Y; Nakamura T; Kawakami Y; Saito Y; Kuzumoto K; Kubota N; Yumoto K; Ishii K
    Jpn J Infect Dis; 2012; 65(6):548-50. PubMed ID: 23183211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orally administered colistin leads to colistin-resistant intestinal flora and fails to prevent faecal colonisation with extended-spectrum β-lactamase-producing enterobacteria in hospitalised newborns.
    Strenger V; Gschliesser T; Grisold A; Zarfel G; Feierl G; Masoud L; Hoenigl M; Resch B; Müller W; Urlesberger B
    Int J Antimicrob Agents; 2011 Jan; 37(1):67-9. PubMed ID: 21074372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of faecal carriage of ESBL-producing Enterobacteriaceae in Norwegian patients with gastroenteritis.
    Jørgensen SB; Samuelsen O; Sundsfjord A; Bhatti SA; Jørgensen I; Sivapathasundaram T; Leegaard TM
    Scand J Infect Dis; 2014 Jun; 46(6):462-5. PubMed ID: 24702690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae blood isolates with inducible AmpC β-lactamase.
    Cheong HS; Ko KS; Kang CI; Chung DR; Peck KR; Song JH
    Microb Drug Resist; 2012 Aug; 18(4):446-52. PubMed ID: 22409779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of colonization with extended-spectrum beta-lactamase (ESBL)-producing enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing enterobacteriaceae among patients during hospitalization.
    Friedmann R; Raveh D; Zartzer E; Rudensky B; Broide E; Attias D; Yinnon AM
    Infect Control Hosp Epidemiol; 2009 Jun; 30(6):534-42. PubMed ID: 19419270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended-spectrum beta-lactamase-producing Enterobacteriaceae carriage upon hospital admission: prevalence and risk factors.
    Shitrit P; Reisfeld S; Paitan Y; Gottesman BS; Katzir M; Paul M; Chowers M
    J Hosp Infect; 2013 Nov; 85(3):230-2. PubMed ID: 24080081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicentre cohort study on colonization and infection with ESBL-producing Enterobacteriaceae in high-risk patients with haematological malignancies.
    Vehreschild MJ; Hamprecht A; Peterson L; Schubert S; Häntschel M; Peter S; Schafhausen P; Rohde H; Lilienfeld-Toal MV; Bekeredjian-Ding I; Libam J; Hellmich M; Vehreschild JJ; Cornely OA; Seifert H
    J Antimicrob Chemother; 2014 Dec; 69(12):3387-92. PubMed ID: 25103492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rectal Carriage of Extended-Spectrum-Beta-Lactamase-Producing Enterobacteriaceae in Hospitalized Patients: Selective Preenrichment Increases Yield of Screening.
    Kluytmans-van den Bergh MF; Verhulst C; Willemsen LE; Verkade E; Bonten MJ; Kluytmans JA
    J Clin Microbiol; 2015 Aug; 53(8):2709-12. PubMed ID: 25994164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enterobacteriaceae bacteremia: risk factors for ESBLPE.
    Neulier C; Birgand G; Ruppé É; Armand-Lefèvre L; Lolom I; Yazdanpanah Y; Lucet JC; Andremont A
    Med Mal Infect; 2014 Jan; 44(1):32-8. PubMed ID: 24321202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and risk factors for faecal extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) carriage derived from residents of seven nursing homes in western Shanghai, China.
    Zhao SY; Zhang J; Zhang YL; Wang YC; Xiao SZ; Gu FF; Guo XK; Ni YX; Han LZ
    Epidemiol Infect; 2016 Mar; 144(4):695-702. PubMed ID: 26260355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of extended-spectrum β-lactamase producing Enterobacter spp. in patients with bacteremia in a tertiary hospital in southern Brazil.
    Nogueira Kda S; Paganini MC; Conte A; Cogo LL; Taborda de Messias Reason I; da Silva MJ; Dalla-Costa LM
    Enferm Infecc Microbiol Clin; 2014 Feb; 32(2):87-92. PubMed ID: 23587705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and risk factors of infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae.
    Nakai H; Hagihara M; Kato H; Hirai J; Nishiyama N; Koizumi Y; Sakanashi D; Suematsu H; Yamagishi Y; Mikamo H
    J Infect Chemother; 2016 May; 22(5):319-26. PubMed ID: 26968486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis.
    Muro S; Garza-González E; Camacho-Ortiz A; González GM; Llaca-Díaz JM; Bosques F; Rositas F
    Chemotherapy; 2012; 58(3):217-24. PubMed ID: 22814216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae is common 12 months after infection and is related to strain factors.
    Titelman E; Hasan CM; Iversen A; Nauclér P; Kais M; Kalin M; Giske CG
    Clin Microbiol Infect; 2014 Aug; 20(8):O508-15. PubMed ID: 24450760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.